Robotic Radiotherapy Market Report 2026

The robotic radiotherapy market size has grown rapidly in recent years. It will grow from $1.17 billion in 2025 to $1.29 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increasing cancer incidence rates, expansion of radiotherapy infrastructure in hospitals, advancements in linear accelerator technologies, rising preference for non-invasive cancer treatments, improved availability of precision imaging systems.

The robotic radiotherapy market size is expected to see rapid growth in the next few years. It will grow to $1.92 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to growing adoption of personalized oncology treatments, rising investments in robotic cancer care infrastructure, increasing demand for motion-adaptive radiotherapy, expansion of proton and particle therapy centers, technological advancements in AI-driven treatment planning. Major trends in the forecast period include increasing adoption of real-time tumor motion tracking, rising use of image-guided robotic radiation systems, growing demand for personalized radiotherapy planning, expansion of non-invasive cancer treatment protocols, enhanced focus on sub-millimeter radiation accuracy.

The increasing demand for minimally invasive procedures is anticipated to drive the growth of the robotic radiotherapy market in the coming years. This demand is fueled by advancements in medical technology, a growing patient preference for shorter recovery times and fewer complications, and the rising adoption of these procedures by healthcare providers due to their cost-effectiveness and improved clinical outcomes. Robotic radiotherapy improves the precision and efficiency of minimally invasive procedures by delivering highly targeted radiation doses to tumors while minimizing damage to surrounding healthy tissues. This approach reduces complications, accelerates recovery, and meets the increasing need for advanced, patient-centered treatment options. For example, in June 2024, the American Society of Plastic Surgeons, a US-based professional organization, reported a 7 percent growth in minimally invasive procedures in 2023, surpassing surgical procedures by 2 percent. Neuromodulator injections and hyaluronic acid fillers each exceeded 9 million and 5 million treatments, respectively. Therefore, the rising demand for minimally invasive procedures is supporting the growth of the robotic radiotherapy market.

Leading companies in the robotic radiotherapy market are emphasizing the development of innovative products with advanced technologies, such as AI-powered precision, which allows tasks to be performed with exceptional accuracy, consistency, and minimal error. Robotic precision improves accuracy, reduces human error, enhances consistency, minimizes tissue damage, and speeds up recovery through the use of sensors, actuators, and algorithms. For instance, in January 2024, Tampa General Hospital, a US-based cancer center, introduced CyberKnife S7, an AI-driven radiosurgery system. This technology represents a notable advancement in cancer treatment, offering a non-invasive, precise option for patients with a variety of conditions, including both benign and malignant tumors, as well as neurological disorders. The CyberKnife S7 delivers targeted radiation while minimizing harm to surrounding healthy tissues, providing a less invasive alternative to conventional surgical approaches.

In April 2024, GE HealthCare, a US-based provider of medical imaging systems, diagnostic technologies, and digital healthcare solutions, acquired MIM Software for an undisclosed sum. Through this acquisition, GE HealthCare aims to enhance its precision care strategy by integrating advanced AI-powered imaging analytics and radiation oncology workflow solutions to improve clinical efficiency and personalize treatment. MIM Software, a US-based company, offers AI-enabled software for radiation oncology, molecular radiotherapy, diagnostic imaging, and urology, catering to hospitals, imaging centers, and research institutions globally.

Major companies operating in the robotic radiotherapy market are Siemens Healthineers AG, GE Healthcare Technologies Inc, Varian Medical Systems, Elekta AB, Accuray Incorporated, Brainlab AG, Mevion Medical Systems Inc, ViewRay Technologies Inc, RaySearch Laboratories AB, VisionRT Ltd, MIM Software Inc, CIVCO Radiotherapy, ProNova Solutions, IBA Group, Xcision Medical Systems LLC, C RAD AB, RefleXion Medical Inc, Zap Surgical Systems Inc, Hitachi High Tech Corporation, Toshiba Medical Systems Corporation, Philips Radiation Oncology Systems, Shinva Medical Instrument Co Ltd, Neusoft Medical Systems Co Ltd, United Imaging Healthcare Radiotherapy.

North America was the largest region in the robotic radiotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic radiotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the robotic radiotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the robotic radiotherapy market by increasing the cost of imported linear accelerators, robotic arms, imaging sensors, precision electronics, and treatment planning software systems. Hospitals and cancer treatment centers in North America and Europe are most affected due to reliance on imported high-end radiotherapy equipment, while Asia-Pacific faces cost pressure on technology-intensive system procurement. These tariffs are raising capital investment requirements and extending equipment upgrade cycles. However, they are also encouraging localized manufacturing, regional system integration capabilities, and long-term investments in domestic radiotherapy technology development.

The robotic radiotherapy market research report is one of a series of new reports that provides robotic radiotherapy market statistics, including robotic radiotherapy industry global market size, regional shares, competitors with a robotic radiotherapy market share, detailed robotic radiotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the robotic radiotherapy industry. This robotic radiotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Robotic radiotherapy is a cutting-edge cancer treatment technique that integrates robotic technology with precise radiation delivery to target tumors with sub-millimeter precision. It employs real-time imaging and motion tracking to adjust for tumor movement, such as that caused by respiration, ensuring minimal impact on surrounding healthy tissues. This method enables non-invasive, highly personalized therapies, enhancing patient outcomes and reducing side effects.

The primary products in the robotic radiotherapy market include radiotherapy systems, software, and 3D cameras (surface-guided). Radiotherapy systems are advanced medical devices and technologies used to treat cancer and other conditions through radiation application. The technologies comprise linear accelerators, conventional linear accelerators, magnetic resonance imaging (MRI) - linear accelerators, stereotactic radiation therapy systems, CyberKnife, Gamma Knife, particle therapy, and proton beam therapy, with applications across prostate cancer, breast cancer, lung cancer, head and neck cancer, and colorectal cancer. The key end users consist of hospitals and independent radiotherapy centers.

The robotic radiotherapy market consists of revenues earned by entities by providing services such as treatment planning services, imaging and diagnostics, robotic system operation, and maintenance. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic radiotherapy market also includes sales of linear accelerators, radiotherapy accessories, immobilization devices, shielding equipment, and fiducial markers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.